Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory Mantle Cell Lymphoma: Real‐World Outcomes, Late Relapse Patterns, and Clinical Utility in the Chimeric Antigen Receptor T‐Cell Era

ABSTRACT Background Allogeneic hematopoietic cell transplantation (alloHCT) remains a curative option for relapsed or refractory (r/r) mantle cell lymphoma (MCL), although its role has shifted in the era of Bruton tyrosine kinase inhibition (BTKi) and chimeric antigen receptor T‐cell (CAR‐T) therapy...

Descripció completa

Dades bibliogràfiques

Autors principals:	Enver Aydilek, Paolo Mazzeo, Justin Hasenkamp, Markus Maulhardt, Tobias Tix, Evgenii Shumilov, Gerald Wulf
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2026-06-01
Col·lecció:	eJHaem
Matèries:	allogeneic hematopoietic cell transplantation CAR‐T era late relapse mantle cell lymphoma relapsed or refractory disease
Accés en línia:	https://doi.org/10.1002/jha2.70318
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!